A prospective observational study on efficacy and relapse prevention markers in repetitive transcranial magnetic stimulation therapy for depression

A prospective observational study on efficacy and relapse prevention markers in repetitive transcranial magnetic stimulation therapy for depression - A prospective observational study on efficacy and relapse prevention markers in repetitive transcranial magnetic stimulation therapy for depression

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043768

Enrollment

Registered

2021-03-29

Start date

2021-03-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with treatment resistant depression who receive transcranial magnetic stimulation therapy

Exclusion criteria

Exclusion criteria: Implanted electronic devices/magnetic material Claustrophobia Subjects who are judged as unsuitable for participation in this study by medical doctor

Design outcomes

Primary

Measure	Time frame
Efficacy and relapse rate in transcranial magnetic stimulation therapy Inflammatory and oxidative stress marker in peripheral blood Electroencephalography Head magnetic resonance imaging	—

Countries

Japan

Contacts

Public ContactShun Takahashi

Wakayama Medical University Department of Neuropsychiatry

cr-psy@wakayama-med.ac.jp073-447-2300

Outcome results